Considering the insufficient sample size of uncommon gastric cancer subtypes (n=1 for squamous cell carcinoma and n=0 for adenosquamous carcinoma), which precluded meaningful statistical analysis, these rare variants were omitted from HER2 assessment to maintain analytical validity. This evidence concerns the gene ERBB2 and adenosquamous carcinoma.